Buy Brezivaptan Cas 1370444-22-6

Buy Brezivaptan Cas 1370444-22-6

Brezivaptan^[1] (developmental code names ANC-501, THY-1773, TS-121) is an orally active, selective vasopressin V_1B receptor antagonist which is under development by Taisho Pharmaceutical for the adjunctive treatment of major depressive disorder.^[2][3][4] As of November 2022, it is in phase II clinical trials for this indication.^[2][3][5]

• ABT-436
• Balovaptan
• List of investigational antidepressants
• Nelivaptan
• SRX-246